ONDANSETRON Fresenius i.v. 4 mg/2ml amp 5 pce
7680630710017
CH-63071
A04AA01
01.09.0.
Reimbursement limitations:
EMETCHEMOTHE
Chimiothérapie fortement émétogène.
1 / 2
google
Details
- Product number
- 6307101
- CPT
- -
- Packaging group
- 5x2 ml
- Unit
- Ampulle(n)
- Composition
- ondansetronum 4 mg ut ondansetroni hydrochloridum dihydricum, natrii chloridum, acidum citricum monohydricum, natrii citras dihydricus, aqua ad iniectabile ad solutionem pro 2 ml corresp. natrium 6.68 mg.
Articles (1)
Ondansetron Fresenius i.v. 4 mg/2 ml, Konzentrat zur Herstellung einer Injektions- /Infusionslösung
Konzentrat
5x2 ml
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
6.68 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 50.05
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/09/2022
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 63071
- Drug name
- Ondansetron Fresenius i.v., Konzentrat zur Herstellung einer Injektions- /Infusionslösung
- Galenic form
- KOIN
- ATC Code
- A04AA01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 01/11/2013
- Authorization expiration date
- 31/12/9999
- IT number
- 01.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ONDANSETRON Fresenius i.v. 4 mg/2ml amp 5 pce
- Description (DE)
- ONDANSETRON Fresenius i.v. 4 mg/2ml Amp 5 Stk
- Market launch
- 01/11/2013
- Narcotic (BTM)
- No